| News & Announcements | Notification of Upcoming Changes to Temporary COVID-19 Waivers of Certain Requirements for Respiratory Equipment/Related Supplies AND DME/POS | | | | | | 6/4/2021 | | | |
| News & Announcements | Notification of Upcoming Changes to Pharmacologic Nuclear Stress Testing in response to COVID-19 | | | | | | 6/15/2021 | | | |
| News & Announcements | Pharmaceutical Treatments of COVID-19 for AmeriHealth Pennsylvania Members (Updated June 23, 2021) | | | | | | 6/23/2021 | | | |
| News & Announcements | Pharmaceutical Treatments of COVID-19 for AmeriHealth New Jersey Members (Updated June 23, 2021) | | | | | | 6/23/2021 | | | |
| Notifications | eviCore Lab Management (AmeriHealth) | 06.02.52u | 6/2/2021 3:00 PM | 7/1/2021 | | | 6/2/2021 | Coverage and/or Reimbursement Position;Medical Necessity Criteria | | |
| Notifications | Enfortumab vedotin-ejfv (Padcev®) | 08.00.43b | 6/4/2021 1:00 PM | 7/12/2021 | | | 6/4/2021 | Medical Necessity Criteria | | |
| Notifications | Evaluation and Treatment of Erectile Dysfunction (ED) | 11.11.01j | 6/8/2021 11:00 AM | 9/13/2021 | | | 6/8/2021 | Medical Necessity Criteria;General Description, Guidelines, or Informational Update | | |
| Notifications | Transcutaneous Electrical Nerve Stimulators (TENS) and Associated Supplies | 05.00.74f | 6/10/2021 2:00 PM | 7/12/2021 | | | 6/10/2021 | Medical Necessity Criteria | | |
| Notifications | High-Technology Radiology Services | 09.00.46ag | 6/14/2021 2:00 PM | 9/12/2021 | | | 6/14/2021 | General Description, Guidelines, or Informational Update | | |
| Updated Policies | Sacral Nerve Stimulation (SNS) and Posterior Tibial Nerve Stimulation (PTNS) for the Control of Incontinence | 11.17.04t | | 6/7/2021 | | | 6/7/2021 | Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Enzyme Replacement for the Treatment of Gaucher's Disease | 08.00.51k | | 6/7/2021 | | | 6/7/2021 | Medical Necessity Criteria;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Neuromuscular Electrical Stimulators (NMES) and Functional Electrical Stimulators (FES) | 05.00.73e | | 6/7/2021 | | | 6/7/2021 | Medical Necessity Criteria | | |
| Updated Policies | Blinatumomab (Blincyto®) | 08.01.21d | | 6/7/2021 | | | 6/7/2021 | Medical Necessity Criteria;Medical Coding | | |
| Updated Policies | Polatuzumab Vedotin-Piiq (Polivy®) | 08.01.59c | | 6/7/2021 | | | 6/7/2021 | Medical Necessity Criteria | | |
| Updated Policies | Daratumumab (Darzalex®), Daratumumab, and Hyaluronidase-fihj (Darzalex Faspro®) | 08.01.29i | | 6/7/2021 | | | 6/7/2021 | Medical Necessity Criteria;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Modifier 66: Surgical Team | 00.10.17l | | 6/7/2021 | | | 6/7/2021 | Medical Coding;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Self-Administered Drugs | 08.00.78ah | | 6/21/2021 | | | 6/21/2021 | Coverage and/or Reimbursement Position;Medical Coding | | |
| Updated Policies | Modifier 57: Decision for Surgery | 03.00.16p | | 6/21/2021 | | | 6/21/2021 | General Description, Guidelines, or Informational Update | | |
| Updated Policies | Autonomic Nervous System Testing | 07.03.23d | | 6/21/2021 | | | 6/21/2021 | Medical Coding | | |
| Updated Policies | Modifier 76: Repeat Procedure or Service by Same Physician or Other Qualified Health Care Professional | 03.00.02c | | 6/21/2021 | | | 6/21/2021 | General Description, Guidelines, or Informational Update | | |
| Updated Policies | Modifier 77: Repeat Procedure or Service by Another Physician or Other Qualified Health Care Professional | 03.00.11c | | 6/21/2021 | | | 6/21/2021 | General Description, Guidelines, or Informational Update | | |
| Updated Policies | Lipectomy and Liposuction | 11.08.03k | 3/30/2021 2:00 PM | 6/28/2021 | | | 6/28/2021 | Coverage and/or Reimbursement Position;Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update | | |
| Reissue Policies | Neuropsychological Testing for Neurologically Based Conditions | 07.03.08j | | 10/1/2020 | 6/2/2021 | | 6/2/2021 | | | |
| Reissue Policies | Cataract Surgery | 11.01.07e | | 1/1/2020 | 6/2/2021 | | 6/2/2021 | | | |
| Reissue Policies | Implantation of Intrastromal Corneal Ring Segments (ICRS) | 11.05.11c | | 9/7/2016 | 6/2/2021 | | 6/2/2021 | | | |
| Reissue Policies | Surgical Correction of Strabismus | 11.05.07d | | 9/7/2016 | 6/2/2021 | | 6/2/2021 | | | |
| Reissue Policies | Uterine Artery Embolization | 11.06.04k | | 5/20/2019 | | | 6/2/2021 | | | |
| Reissue Policies | Bone Mineral Density (BMD) Testing | 09.00.04k | | 3/10/2020 | | | 6/2/2021 | | | |
| Reissue Policies | Endometrial Ablation | 11.06.05f | | 5/20/2019 | | | 6/2/2021 | | | |
| Reissue Policies | Extracorporeal Shock Wave Therapy (ESWT) for Musculoskeletal Conditions | 11.14.13g | | 1/1/2017 | 6/2/2021 | | 6/2/2021 | | | |
| Reissue Policies | Photodynamic Therapy (PDT) Using Levulan® Kerastick® or Ameluz® (Aminolevulinic Acid HCl [ALA]) | 07.07.03m | | 7/1/2019 | 6/2/2021 | | 6/2/2021 | | | |
| Reissue Policies | Scanning Computerized Ophthalmic Diagnostic Imaging (SCODI) | 07.13.06l | | 9/30/2020 | 6/1/2021 | | 6/2/2021 | | | |
| Reissue Policies | Refractive Keratoplasty | 11.05.01f | | 7/1/2019 | 6/2/2021 | | 6/2/2021 | | | |
| Reissue Policies | Laboratory-Based Vestibular Function Testing | 07.03.24b | | 1/1/2021 | 6/2/2021 | | 6/2/2021 | | | |
| Reissue Policies | Procedures for the Treatment of Gastroesophageal Reflux Disease (GERD) | 11.03.11p | | 12/7/2020 | 6/2/2021 | | 6/2/2021 | | | |
| Reissue Policies | Genetic Testing for Inherited Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Mutations (AmeriHealth Administrators) | 06.02.06q | | 7/1/2020 | 6/2/2021 | | 6/2/2021 | | | |
| Reissue Policies | Preimplantation Genetic Testing (AmeriHealth Administrators) | 06.02.24j | | 10/1/2016 | 6/2/2021 | | 6/2/2021 | | | |
| Reissue Policies | Low-level Laser Therapy (LLLT) | 07.00.14g | | 9/30/2019 | 6/2/2021 | | 6/3/2021 | | | |
| Reissue Policies | Short-term Interstitial Continuous Glucose Monitoring Systems (CGMSs) | 05.00.24r | | 10/26/2020 | 6/2/2021 | | 6/3/2021 | | | |
| Reissue Policies | Treatment of Medical and Surgical Complications | 11.00.02f | | 8/26/2015 | 6/2/2021 | | 6/3/2021 | | | |
| Reissue Policies | Insulin Pumps and Long-Term Interstitial Continuous Glucose Monitoring Systems | 05.00.79c | | 10/26/2020 | 6/2/2021 | | 6/3/2021 | | | |
| Reissue Policies | Subcutaneous Implantable Cardioverter Defibrillator (S-ICD) for Treating Life-threatening Ventricular Tachyarrhythmia | 05.00.77b | | 3/22/2021 | 6/2/2021 | | 6/3/2021 | | | |
| Reissue Policies | Pharmacogenetics and Metabolite Monitoring for Using Azathioprine (AZA)/6-Mercaptopurine (6-MP) Therapy (AmeriHealth Administrators) | 06.02.18l | | 4/1/2020 | 6/2/2021 | | 6/3/2021 | | | |
| Reissue Policies | Presumptive and Definitive Drug Testing in Substance Abuse and Pain Management Treatments | 06.02.44n | | 1/1/2021 | 6/2/2021 | | 6/3/2021 | | | |
| Reissue Policies | Therapeutic Drug Monitoring for Antidepressants, Antipsychotics, or Antiepileptics | 06.02.55 | | 4/7/2017 | 6/2/2021 | | 6/3/2021 | | | |
| Reissue Policies | Magnetic Resonance Imaging (MRI)-Guided Focused Ultrasound Ablation | 11.06.06f | | 1/1/2021 | 6/2/2021 | | 6/3/2021 | | | |
| Reissue Policies | Equipment, Supplies, and Pharmaceuticals for the Treatment of Diabetes | 05.00.05m | | 10/26/2020 | 6/2/2021 | | 6/3/2021 | | | |
| Reissue Policies | Acute Care Facility Inpatient Transfers | 12.04.04a | | 12/30/2019 | 6/2/2021 | | 6/3/2021 | | | |
| Reissue Policies | Hair Transplants and Cranial Prostheses (Wigs) | 11.08.01g | | 9/9/2019 | 6/2/2021 | | 6/3/2021 | | | |
| Reissue Policies | Percutaneous Discectomy | 11.15.15g | | 12/1/2017 | 6/2/2021 | | 6/3/2021 | | | |
| Reissue Policies | Patient Lifts | 05.00.42h | | 2/15/2021 | 6/2/2021 | | 6/4/2021 | | | |
| Reissue Policies | Ostomy Supplies | 05.00.50l | | 8/3/2020 | 6/2/2021 | | 6/4/2021 | | | |
| Reissue Policies | Transcranial Magnetic Stimulation (TMS) | 07.03.22d | | 7/1/2019 | 6/2/2021 | | 6/4/2021 | | | |
| Reissue Policies | Chiropractic Spinal and Extraspinal Manipulation Therapy | 10.02.02j | | 5/18/2020 | 6/2/2021 | | 6/4/2021 | | | |
| Reissue Policies | Pharmacogenetic Testing to Determine Drug Sensitivity (AmeriHealth Administrators) | 06.02.30e | | 7/1/2016 | 6/2/2021 | | 6/4/2021 | | | |
| Reissue Policies | Reduction Mammoplasty | 11.08.02i | | 1/1/2021 | 6/16/2021 | | 6/16/2021 | | | |
| Reissue Policies | Home-Based Sleep Studies | 07.03.01a | | 10/1/2020 | 6/16/2021 | | 6/16/2021 | | | |
| Reissue Policies | Medical and Surgical Treatment of Temporomandibular Joint Disorder | 07.08.03g | | 11/26/2020 | 6/16/2021 | | 6/16/2021 | | | |
| Reissue Policies | Trigger Point Injections | 11.14.02p | | 11/27/2020 | 6/16/2021 | | 6/16/2021 | | | |
| Reissue Policies | Gastric Electrical Stimulation (Enterra™), Gastric Pacing | 11.03.15i | | 11/30/2020 | 6/16/2021 | | 6/16/2021 | | | |
| Reissue Policies | Surgery for Gynecomastia | 11.08.12h | | 5/18/2016 | 6/16/2021 | | 6/17/2021 | | | |
| Reissue Policies | Nucleoplasty | 11.15.19e | | 5/7/2014 | 6/16/2021 | | 6/17/2021 | | | |
| Reissue Policies | Migraine Deactivation Surgery | 11.15.24a | | 3/11/2015 | 6/16/2021 | | 6/17/2021 | | | |
| Reissue Policies | Photodynamic Therapy (PDT) Using Verteporfin (Visudyne®) | 07.13.05k | | 5/7/2018 | 6/16/2021 | | 6/17/2021 | | | |
| Reissue Policies | Surgical Treatments of Athletic Pubalgia | 11.14.26a | | 6/3/2015 | 6/16/2021 | | 6/17/2021 | | | |
| Reissue Policies | Wireless Capsule Endoscopy (WCE) as a Diagnostic Technique in Disorders of the Small Bowel, Esophagus, and Colon | 07.05.02n | | 12/16/2016 | 6/16/2021 | | 6/17/2021 | | | |
| Reissue Policies | Aqueous Shunts, Microstents, Viscocanalostomy, and Canaloplasty for the Treatment of Glaucoma | 11.05.16i | | 11/30/2020 | 6/16/2021 | | 6/17/2021 | | | |
| Reissue Policies | Lysis of Epidural Adhesions | 11.15.13d | | 2/14/2016 | 6/16/2021 | | 6/17/2021 | | | |
| Reissue Policies | Mentoplasty or Genioplasty | 11.14.01g | | 6/25/2017 | 6/16/2021 | | 6/17/2021 | | | |
| Reissue Policies | Stem-Cell Therapy for Orthopedic Applications and Autologous Platelet-Derived Growth Factors (PDGFs)/Platelet-Rich Plasmas (PRPs) for Acute or Chronic Wound Healing and Other Miscellaneous Conditions | 07.07.09g | | 12/30/2019 | 6/16/2021 | | 6/17/2021 | | | |
| Reissue Policies | Vagus Nerve Stimulation (VNS) | 11.15.16p | | 3/26/2021 | 6/16/2021 | | 6/17/2021 | | | |
| Reissue Policies | Injectable Dermal Fillers | 05.00.62h | | 1/1/2017 | 6/16/2021 | | 6/17/2021 | | | |
| Reissue Policies | Prophylactic Mastectomy, Oophorectomy/Salpingo-Oophorectomy, and Hysterectomy | 11.08.19o | | 12/31/2019 | 6/16/2021 | | 6/21/2021 | | | |
| Reissue Policies | Bioimpedence for the Detection of Lymphedema | 07.06.03b | | 12/29/2014 | 6/16/2021 | | 6/21/2021 | | | |
| Reissue Policies | Radium Ra 223 dichloride (Xofigo®) Injection (AmeriHealth Administrators) | 08.01.14e | | 3/1/2019 | 6/16/2021 | | 6/21/2021 | | | |
| Reissue Policies | Cosmetic Procedures | 12.01.03a | | 11/19/2020 | 6/16/2021 | | 6/21/2021 | | | |
| Reissue Policies | Complete Decongestive Therapy (CDT) | 07.06.01b | | 12/30/2013 | 6/16/2021 | | 6/21/2021 | | | |
| Reissue Policies | Otoplasty or Non-Surgical External Ear Molding | 11.01.01j | | 9/8/2018 | 6/16/2021 | | 6/21/2021 | | | |
| Reissue Policies | Sleep Disorder Testing and Positive Airway Pressure Therapy Services and Supplies | 07.03.05x | | 7/18/2020 | 6/16/2021 | | 6/21/2021 | | | |
| Reissue Policies | Lutathera® (Lutetium Lu 177 Dotatate) (AmeriHealth Administrators) | 08.01.57 | | 6/28/2019 | 6/16/2021 | | 6/21/2021 | | | |
| Reissue Policies | Solid Organ Transplantation and Procurement Cost of Organs and Tissues | 11.00.09f | | 12/31/2017 | 6/16/2021 | | 6/22/2021 | | | |
| Reissue Policies | Ovarian and Internal Iliac Vein Embolization as Treatment for Pelvic Congestion Syndrome | 11.06.07d | | 4/23/2018 | 6/16/2021 | | 6/22/2021 | | | |
| Reissue Policies | Physical Medicine, Rehabilitation, and Habilitation Services | 10.03.01l | | 3/30/2020 | 6/30/2021 | | 6/30/2021 | | | |
| Reissue Policies | Air Ambulance Services | 12.04.03c | | 1/1/2019 | 6/30/2021 | | 6/30/2021 | | | |